Form 8-K Context Therapeutics For: Jul 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Context Therapeutics gets Nasdaq minimum bid price deficiency notice
July 31, 2026 4:11 PM EDTContext Therapeutics Inc. (NASDAQ: CNTX) received a written notice from the Nasdaq Listing Qualifications Department on July 29, 2026, stating the company is not in compliance with Nasdaq Listing Rule 5550(a)(2), known as the Minimum Bid Price Rule.
The notice was issued because the company's common... More
